Creative Planning Neogenomics Inc Transaction History

Creative Planning

$106 Billion
Q1 2025

A detailed history of Creative Planning transactions in Neogenomics Inc stock. As of the latest transaction made, Creative Planning holds 13,895 shares of NEO stock, worth $104,212. This represents 0.0% of its overall portfolio holdings.

Number of Shares

13,895

Previous 22,325 37.76%

Holding current value

$104,212

Previous $367,000 64.31%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$9.09 - $18.61 $76,628 - $156,882	-8,430 Reduced 37.76%	13,895 $131,000
Q4 2024 Feb 14, 2025	SELL	$13.0 - $18.43 $15,886 - $22,521	-1,222 Reduced 5.19%	22,325 $367,000
Q3 2024 Oct 11, 2024	BUY	$13.4 - $17.73 $93,853 - $124,180	7,004 Added 42.34%	23,547 $347,000
Q2 2024 Aug 15, 2024	SELL	$13.01 - $15.77 $14,415 - $17,473	-1,108 Reduced 6.28%	16,543 $229,000
Q1 2024 May 10, 2024	BUY	$14.06 - $16.79 $10,502 - $12,542	747 Added 4.42%	17,651 $277,000
Q4 2023 Feb 14, 2024	SELL	$11.67 - $20.73 $993,210 - $1.76 Million	-85,108 Reduced 83.43%	16,904 $273,000
Q3 2023 Nov 16, 2023	BUY	$12.15 - $17.85 $13,122 - $19,278	1,080 Added 1.07%	102,012 $1.25 Million
Q2 2023 Jul 21, 2023	SELL	$14.1 - $19.83 $7,980 - $11,223	-566 Reduced 0.56%	100,932 $1.62 Million
Q1 2023 May 15, 2023	SELL	$9.09 - $19.45 $63 - $136	-7 Reduced 0.01%	101,498 $1.77 Million
Q4 2022 Feb 10, 2023	BUY	$6.45 - $12.07 $233,928 - $437,754	36,268 Added 55.59%	101,505 $937,000
Q3 2022 Nov 03, 2022	BUY	$7.86 - $12.91 $320,357 - $526,185	40,758 Added 166.5%	65,237 $562,000
Q2 2022 Aug 15, 2022	BUY	$7.06 - $13.97 $89,852 - $177,796	12,727 Added 108.3%	24,479 $200,000
Q1 2022 May 16, 2022	SELL	$12.15 - $35.28 $2,697 - $7,832	-222 Reduced 1.85%	11,752 $143,000
Q4 2021 Feb 11, 2022	SELL	$30.49 - $48.49 $53,022 - $84,324	-1,739 Reduced 12.68%	11,974 $409,000
Q3 2021 Nov 10, 2021	SELL	$41.66 - $52.52 $266,707 - $336,233	-6,402 Reduced 31.83%	13,713 $662,000
Q2 2021 Aug 04, 2021	BUY	$36.62 - $51.69 $310,208 - $437,865	8,471 Added 72.75%	20,115 $908,000
Q1 2021 Apr 30, 2021	BUY	$41.56 - $59.88 $134,155 - $193,292	3,228 Added 38.36%	11,644 $562,000
Q4 2020 Jan 29, 2021	BUY	$36.08 - $56.47 $40,229 - $62,964	1,115 Added 15.27%	8,416 $453,000
Q3 2020 Nov 05, 2020	BUY	$33.26 - $40.48 $242,831 - $295,544	7,301 New	7,301 $269,000

Others Institutions Holding NEO

# of Institutions

288

Shares Held

127M

Call Options Held

942K

Put Options Held

172K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $943M
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Neogenomics Inc Transaction History